Julien Dilly

9PUBLICATIONS
157CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 17, 2025
CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer.

Szu-Aun Long, Haley Todd, Grace Goodhart

|Jul 24, 2025
A neomorphic protein interface catalyzes covalent inhibition of RAS<sup>G12D</sup> aspartic acid in tumors.

Caroline Weller, G Leslie Burnett, Lingyan Jiang

|Apr 28, 2025
Response and Resistance to RAS Inhibition in Cancer.

Richard Y Ebright, Julien Dilly, Alice T Shaw

|Nov 12, 2024
Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer.

Urszula N Wasko, Jingjing Jiang, Tanner C Dalton

|Jul 08, 2024
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer.

Julien Dilly, Megan T Hoffman, Laleh Abbassi

|Apr 08, 2024
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy.

Matthew Holderfield, Bianca J Lee, Jingjing Jiang

Pageof 2